Genticel has completed recruitment of patients for its Phase I trial with ProCervix, its therapeutic vaccine against human papillomavirus (HPV) types 16 and 18
October, 19 2011

Genticel named Dr Didier Hoch, former president of Sanofi-Pasteur MSD, to its supervisory board - July 4, 2011
July, 11 2011

Approval for clinical trial of ProCervix
July, 23 2010

Genticel lève 13.1 millions d'euros
March, 09 2010

Genticel secures EUR 13.1M (USD 17.7M) in capital funding
March, 09 2010